MiMedx Group, Inc. (MDXG) vs OmniAb, Inc. (OABI)
A side-by-side comparison of MiMedx Group, Inc. and OmniAb, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDXG
MiMedx Group, Inc.
$4.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OABI
OmniAb, Inc.
$4.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MDXG vs OABI
growth of $100 · dividends reinvested · last 5yMDXG -28.1% (-6.4%/yr)OABI -49.6% (-12.8%/yr)MDXG compounded faster over this window
MDXG OABI
MDXG vs OABI: by the numbers
- •MDXG is the larger company ($673M vs $631M market cap).
- •MDXG is profitable (1.76% net margin) while OABI runs a net loss (-115.18%).
- •MDXG grew revenue faster over the past five years (6.36% vs -4.31% CAGR).
Metrics side by side
Valuation
| Metric | MDXG | OABI |
|---|---|---|
| P/E ratio | 115.50 | N/A |
| P/S ratio | 1.90 | 16.41 |
| P/B ratio | 3.12 | 2.42 |
| EV / EBITDA | 26.41 | N/A |
| FCF yield | 6.03% | N/A |
Profitability
| Metric | MDXG | OABI |
|---|---|---|
| Gross margin | 78.85% | -18.17% |
| Operating margin | 15.26% | -383.15% |
| Net margin | 1.76% | -115.18% |
| ROE | 2.89% | -17.01% |
| ROIC | 1.97% | -17.48% |
Growth (annualized)
| Metric | MDXG | OABI |
|---|---|---|
| Revenue CAGR (5Y) | 6.36% | -4.31% |
| Total return CAGR (5Y) | -4.94% | -13.17% |
Frequently asked
- Which has grown faster, MDXG or OABI?
- Over the past five years, MDXG grew revenue faster — MDXG at a 6.36% CAGR versus OABI at -4.31%.
- Is MDXG or OABI more profitable?
- MDXG runs the higher net margin — MDXG at 1.76% versus OABI at -115.18%.
- How have MDXG and OABI total returns compared?
- Over the past 5 years, MDXG delivered -4.94% and OABI delivered -13.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MiMedx P/E ratioMiMedx ROEOmniAb ROEMiMedx operating marginOmniAb operating marginMiMedx revenue growthOmniAb revenue growthMiMedx free cash flowOmniAb free cash flow
MiMedx & OmniAb appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.